Study on Herpes Zoster Reactivation Induced by Arsenic in Patients with Acute Promyelocytic Leukemia

Chen Yang Zhao; Xin Xin Zhang; Sha Gong; Shu Chen; Xiao Juan Zhang; Su Hua Wei; Huai Yu Wang

doi:10.19746/j.cnki.issn.1009-2137.2022.01.012

Study on Herpes Zoster Reactivation Induced by Arsenic in Patients with Acute Promyelocytic Leukemia

Chen Yang Zhao
, Xin Xin Zhang
, Sha Gong
, Shu Chen
, Xiao Juan Zhang
, Su Hua Wei
, Huai Yu Wang

The First Affiliated Hospital of Xi’an Jiaotong University

Research output: Contribution to journal › Article › peer-review

Abstract

题目: 砷剂治疗急性早幼粒细胞白血病诱发带状疱疹再激活的研究. 目的: 探讨急性早幼粒细胞白血病（APL）患者静脉应用三氧化二砷或口服复方黄黛片治疗后引起带状疱疹的再激活率. 方法: 回顾性分析西安交通大学第一附属医院血液内科2008-2019年收治的212例接受砷剂治疗的APL患者的临床资料，应用Kaplan-Meier分析、卡方检验、箱式图等对患者进行统计及分析描述，观察应用砷剂后引起的带状疱疹病毒的激活率. 结果: 排除早期死亡病例及早期自动出院的病例，在175例使用砷剂治疗的APL患者中，17例出现带状疱疹再激活，带状疱疹在应用砷剂后10个月内再激活的精确风险为9.7%。砷剂累计中位剂量6.2（2-12）mg/kg. 结论: 砷剂治疗可以诱发带状疱疹病毒较高的再激活率.

Original language	English
Pages (from-to)	72-76
Number of pages	5
Journal	Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology
Volume	30
Issue number	1
DOIs	https://doi.org/10.19746/j.cnki.issn.1009-2137.2022.01.012
State	Published - 1 Feb 2022
Externally published	Yes

Keywords

acute promyelocytic leukemia
arsenic
herpes zoster

Access to Document

10.19746/j.cnki.issn.1009-2137.2022.01.012

Cite this

Zhao, C. Y., Zhang, X. X., Gong, S., Chen, S., Zhang, X. J., Wei, S. H., & Wang, H. Y. (2022). Study on Herpes Zoster Reactivation Induced by Arsenic in Patients with Acute Promyelocytic Leukemia. Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology, 30(1), 72-76. https://doi.org/10.19746/j.cnki.issn.1009-2137.2022.01.012

@article{b0942d8d75594b988f3a4de3684b8a89,

title = "Study on Herpes Zoster Reactivation Induced by Arsenic in Patients with Acute Promyelocytic Leukemia",

abstract = "题目: 砷剂治疗急性早幼粒细胞白血病诱发带状疱疹再激活的研究. 目的: 探讨急性早幼粒细胞白血病（APL）患者静脉应用三氧化二砷或口服复方黄黛片治疗后引起带状疱疹的再激活率. 方法: 回顾性分析西安交通大学第一附属医院血液内科2008-2019年收治的212例接受砷剂治疗的APL患者的临床资料，应用Kaplan-Meier分析、卡方检验、箱式图等对患者进行统计及分析描述，观察应用砷剂后引起的带状疱疹病毒的激活率. 结果: 排除早期死亡病例及早期自动出院的病例，在175例使用砷剂治疗的APL患者中，17例出现带状疱疹再激活，带状疱疹在应用砷剂后10个月内再激活的精确风险为9.7\%。砷剂累计中位剂量6.2（2-12）mg/kg. 结论: 砷剂治疗可以诱发带状疱疹病毒较高的再激活率.",

keywords = "acute promyelocytic leukemia, arsenic, herpes zoster",

author = "Zhao, \{Chen Yang\} and Zhang, \{Xin Xin\} and Sha Gong and Shu Chen and Zhang, \{Xiao Juan\} and Wei, \{Su Hua\} and Wang, \{Huai Yu\}",

year = "2022",

month = feb,

day = "1",

doi = "10.19746/j.cnki.issn.1009-2137.2022.01.012",

language = "英语",

volume = "30",

pages = "72--76",

journal = "Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology",

issn = "1009-2137",

publisher = "Haidian-qu",

number = "1",

}

Zhao, CY, Zhang, XX, Gong, S, Chen, S, Zhang, XJ, Wei, SH & Wang, HY 2022, 'Study on Herpes Zoster Reactivation Induced by Arsenic in Patients with Acute Promyelocytic Leukemia', Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology, vol. 30, no. 1, pp. 72-76. https://doi.org/10.19746/j.cnki.issn.1009-2137.2022.01.012

Study on Herpes Zoster Reactivation Induced by Arsenic in Patients with Acute Promyelocytic Leukemia. / Zhao, Chen Yang; Zhang, Xin Xin; Gong, Sha et al.
In: Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology, Vol. 30, No. 1, 01.02.2022, p. 72-76.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Study on Herpes Zoster Reactivation Induced by Arsenic in Patients with Acute Promyelocytic Leukemia

AU - Zhao, Chen Yang

AU - Zhang, Xin Xin

AU - Gong, Sha

AU - Chen, Shu

AU - Zhang, Xiao Juan

AU - Wei, Su Hua

AU - Wang, Huai Yu

PY - 2022/2/1

Y1 - 2022/2/1

N2 - 题目: 砷剂治疗急性早幼粒细胞白血病诱发带状疱疹再激活的研究. 目的: 探讨急性早幼粒细胞白血病（APL）患者静脉应用三氧化二砷或口服复方黄黛片治疗后引起带状疱疹的再激活率. 方法: 回顾性分析西安交通大学第一附属医院血液内科2008-2019年收治的212例接受砷剂治疗的APL患者的临床资料，应用Kaplan-Meier分析、卡方检验、箱式图等对患者进行统计及分析描述，观察应用砷剂后引起的带状疱疹病毒的激活率. 结果: 排除早期死亡病例及早期自动出院的病例，在175例使用砷剂治疗的APL患者中，17例出现带状疱疹再激活，带状疱疹在应用砷剂后10个月内再激活的精确风险为9.7%。砷剂累计中位剂量6.2（2-12）mg/kg. 结论: 砷剂治疗可以诱发带状疱疹病毒较高的再激活率.

AB - 题目: 砷剂治疗急性早幼粒细胞白血病诱发带状疱疹再激活的研究. 目的: 探讨急性早幼粒细胞白血病（APL）患者静脉应用三氧化二砷或口服复方黄黛片治疗后引起带状疱疹的再激活率. 方法: 回顾性分析西安交通大学第一附属医院血液内科2008-2019年收治的212例接受砷剂治疗的APL患者的临床资料，应用Kaplan-Meier分析、卡方检验、箱式图等对患者进行统计及分析描述，观察应用砷剂后引起的带状疱疹病毒的激活率. 结果: 排除早期死亡病例及早期自动出院的病例，在175例使用砷剂治疗的APL患者中，17例出现带状疱疹再激活，带状疱疹在应用砷剂后10个月内再激活的精确风险为9.7%。砷剂累计中位剂量6.2（2-12）mg/kg. 结论: 砷剂治疗可以诱发带状疱疹病毒较高的再激活率.

KW - acute promyelocytic leukemia

KW - arsenic

KW - herpes zoster

UR - https://www.scopus.com/pages/publications/85124437963

U2 - 10.19746/j.cnki.issn.1009-2137.2022.01.012

DO - 10.19746/j.cnki.issn.1009-2137.2022.01.012

M3 - 文章

C2 - 35123606

AN - SCOPUS:85124437963

SN - 1009-2137

VL - 30

SP - 72

EP - 76

JO - Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology

JF - Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology

IS - 1

ER -

Zhao CY, Zhang XX, Gong S, Chen S, Zhang XJ, Wei SH et al. Study on Herpes Zoster Reactivation Induced by Arsenic in Patients with Acute Promyelocytic Leukemia. Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology. 2022 Feb 1;30(1):72-76. doi: 10.19746/j.cnki.issn.1009-2137.2022.01.012

Study on Herpes Zoster Reactivation Induced by Arsenic in Patients with Acute Promyelocytic Leukemia

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this